Singapore: CSL's plasma product operations in Australia will take on the name of its global plasma business, CSL Behring...
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem received positive results from ...
Australia, known for providing rigorous high quality clinical research and enthusiastic investigators with centers of ...
Singapore: Australia-based Alchemia has provided commercial update on four of its key projects, including its marketed d...
Singapore: Australian Academy of Science and the Indonesian Academy of Sciences have signed a new memorandum of understa...
Singapore: Australia company Bluechiip, which has developed a unique asset-tracking solution initially for cryogenic sam...
Singapore: A phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitax...
Singapore: At the company's annual general meeting in Brisbane last week, AusBiotech announced the appointment of two ne...
Singapore: OxySure Systems, a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its '...
Singapore: The board of Genetic Technologies announced the appointment of Dr Mal Brandon to the position of chairman o...
Singapore: US-based PaxVax, a specialty vaccine company, has confirmed positive efficacy results from 90-day challenge s...
Telemedicine is re-defining access to healthcare in many ways. It has, in particular, proved to be an effective solution...
There has been a significant increase in industry-to-academia and industry-to-industry interactions between Indian and A...
Singapore: Alchemia has been granted a further patent term adjustment for a key HyACT US patent, as well as an important...
Singapore: BioCSL has inked a deal with US-based Immucor to distribute transfusion testing technology in Australia and N...
Singapore: Melbourne-based Phosphagenics completed a pre-clinical study demonstrating that its oxycodone/TPM technology ...
Singapore: Helmedix, an early stage biopharma company developing novel therapies for autoimmune and inflammatory diseas...
